These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 22153765

  • 1. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH, Kuo SC, Lee YT, Chang IC, Yang SP, Chen TL, Fung CP.
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [Abstract] [Full Text] [Related]

  • 2. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX, Hu YJ, Zhou HW, Zhang R, Chen GX.
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [Abstract] [Full Text] [Related]

  • 3. Development of a pyrosequencing assay for rapid assessment of quinolone resistance in Acinetobacter baumannii isolates.
    Deccache Y, Irenge LM, Savov E, Ariciuc M, Macovei A, Trifonova A, Gergova I, Ambroise J, Vanhoof R, Gala JL.
    J Microbiol Methods; 2011 Jul; 86(1):115-8. PubMed ID: 21514328
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels.
    Alcaide E, Blasco MD, Esteve C.
    Res Microbiol; 2010 Jul; 161(1):40-5. PubMed ID: 19900538
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN.
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [Abstract] [Full Text] [Related]

  • 6. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 7. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
    Kim MS, Jun LJ, Shin SB, Park MA, Jung SH, Kim K, Moon KH, Jeong HD.
    J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 9. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
    Kulkarni S, Bala M, Sane S, Pandey S, Bhattacharya J, Risbud A.
    Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
    [Abstract] [Full Text] [Related]

  • 10. Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.
    Lopes BS, Amyes SG.
    Int J Antimicrob Agents; 2013 Feb; 41(2):117-21. PubMed ID: 23217848
    [Abstract] [Full Text] [Related]

  • 11. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR, Tapsall JW, White PA.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [Abstract] [Full Text] [Related]

  • 12. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N, Davies TA, Goldschmidt R.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [Abstract] [Full Text] [Related]

  • 13. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.
    Liang-Yu C, Kuo SC, Liu CY, Luo BS, Huang LJ, Lee YT, Chen CP, Chen TL, Fung CP.
    J Microbiol Immunol Infect; 2011 Oct; 44(5):358-63. PubMed ID: 21524973
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, Piddock LJ.
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [Abstract] [Full Text] [Related]

  • 15. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K, Wołkowicz T, Zacharczuk K, Rzeczkowska M, Chróst A, Bareja E, Olak M, Gierczyński R.
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [Abstract] [Full Text] [Related]

  • 16. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
    Shoji H, Shirakura T, Fukuchi K, Takuma T, Hanaki H, Tanaka K, Niki Y.
    J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
    [Abstract] [Full Text] [Related]

  • 17. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H, Duan G, Zhu J, Zhang W, Xi Y, Fan Q.
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [Abstract] [Full Text] [Related]

  • 19. A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of gyrA and parC Mutations Associated With Fluoroquinolone Resistance in Acinetobacter baumannii.
    Kakuta N, Nakano R, Nakano A, Suzuki Y, Tanouchi A, Masui T, Horiuchi S, Endo S, Kakuta R, Ono Y, Yano H.
    Ann Lab Med; 2020 Jan; 40(1):27-32. PubMed ID: 31432636
    [Abstract] [Full Text] [Related]

  • 20. [Correlation between mutation of GyrA and ParC genes and quinolone resistance in Neisseria gonorrhoeae].
    Xie P, Mi ZH, Li Q, Zhang J, Xiao CY.
    Zhonghua Nan Ke Xue; 2003 Jan; 9(4):275-8. PubMed ID: 12931370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.